Cytodifferentiation: a novel approach to cancer treatment and prevention (Q33183127)

23 July 2017

1 reference

title

Cytodifferentiation: a novel approach to cancer treatment and prevention (English)

1 reference

23 July 2017

Garattini E

1

1 reference

23 July 2017

Terao M

series ordinal

2

1 reference

23 July 2017

language of work or name

1 reference

1 August 2001

1 reference

Current Opinion in Pharmacology

23 July 2017

published in

1 reference

23 July 2017

volume

1

1 reference

23 July 2017

issue

4

1 reference

23 July 2017

page(s)

358-363

1 reference

Return of de-differentiation: why cancer is a developmental disease.

23 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900062-5

7 January 2021

New strategies for the treatment of acute myelogenous leukemia: differentiation induction--present use and future possibilities

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900062-5

7 January 2021

Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900062-5

7 January 2021

Retinoids and chemoprevention of aerodigestive tract cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900062-5

7 January 2021

Differentiation therapy in acute myelogenous leukemia (non-APL).

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900062-5

7 January 2021

Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900062-5

7 January 2021

Acute promyelocytic leukaemia cells resistant to retinoic acid show further perturbation of the RAR alpha signal transduction system.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900062-5

7 January 2021

Human neuroblastoma cell differentiation requires protein kinase C-theta

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900062-5

7 January 2021

Use of arginine to reduce the severity of retinoid-induced hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900062-5

7 January 2021

Structural basis for isotype selectivity of the human retinoic acid nuclear receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900062-5

7 January 2021

Crystal structure of the human RXRalpha ligand-binding domain bound to its natural ligand: 9-cis retinoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900062-5

7 January 2021

Retinoid-dependent growth inhibition, differentiation and apoptosis in acute promyelocytic leukemia cells. Expression and activation of caspases

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900062-5

7 January 2021

Activation of retinoid X receptors induces apoptosis in HL-60 cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900062-5

7 January 2021

Leukocyte alkaline phosphatase a specific marker for the post-mitotic neutrophilic granulocyte: regulation in acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900062-5

7 January 2021

Acute myelogenous leukemia with a t(2;17;4)(p13;q21;p16) aberration: effective treatment with all-trans retinoic acid and granulocyte colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900062-5

7 January 2021

Cross-talk between retinoic acid and interferons: molecular mechanisms of interaction in acute promyelocytic leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900062-5

7 January 2021

Acute promyelocytic leukemia as a model for cross-talk between interferon and retinoic acid pathways: from molecular biology to clinical applications.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900062-5

7 January 2021

Modulation of interferon (IFN)-inducible gene expression by retinoic acid. Up-regulation of STAT1 protein in IFN-unresponsive cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900062-5

7 January 2021

Tyrosine kinase inhibitor STI571 potentiates the pharmacologic activity of retinoic acid in acute promyelocytic leukemia cells: effects on the degradation of RARalpha and PML-RARalpha

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900062-5

7 January 2021

Two distinctly regulated events, priming and triggering, during retinoid-induced maturation and resistance of NB4 promyelocytic leukemia cell line

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900062-5

7 January 2021

Role of vitamin D3 receptor in the synergistic differentiation of WEHI-3B leukemia cells by vitamin D3 and retinoic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900062-5

7 January 2021

Synergistic decrease of clonal proliferation, induction of differentiation, and apoptosis of acute promyelocytic leukemia cells after combined treatment with novel 20-epi vitamin D3 analogs and 9-cis retinoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900062-5

7 January 2021

RAR-independent RXR signaling induces t(15;17) leukemia cell maturation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900062-5

7 January 2021

The role of vitamin D in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900062-5

7 January 2021

Novel ring A stereoisomers of 2-methyl-1alpha,25-dihydroxyvitamin D(3) and 2-methyl-20-epi-1alpha,25-dihydroxyvitamin D(3): transactivation of target genes and modulation of differentiation in human promyelocytic leukemia (HL-60) cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900062-5

7 January 2021

Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900062-5

7 January 2021

Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900062-5

7 January 2021

Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900062-5

7 January 2021

Butyrate-stable monosaccharide derivatives induce maturation and apoptosis in human acute myeloid leukaemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900062-5

7 January 2021

A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900062-5

7 January 2021

CD44 isoforms in normal and leukemic hematopoiesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900062-5

7 January 2021

Ligation of the CD44 adhesion molecule reverses blockage of differentiation in human acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900062-5

7 January 2021

Differentiation of leukemic cells induced by short-course high-dose methylprednisolone in children with different subtypes of acute myeloblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900062-5

7 January 2021

Effects of methylprednisolone on human myeloid leukemic cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900062-5

7 January 2021

10.1016/S1471-4892(01)00062-5

Identifiers

DOI

1 reference

23 July 2017

1 reference